Yu Alex Kato

Yu Alex Kato is a highly experienced professional in the field of translational medicine and research, currently serving as a member of Translational Sciences at Tr1X since September 2023. Prior to this role, Yu Alex held the position of Principal Scientist in Translational Medicine & Translational Research at IconOVir Bio, where notable achievements included developing a biomarker plan for a Phase 1 trial and overseeing key immunogenicity studies. Yu Alex's earlier work at the La Jolla Institute for Immunology involved leading projects on B cell immunity to SARS-CoV-2 and HIV vaccination strategies, contributing to significant publications in top-tier journals. Academic credentials include a PhD in Immunology and a Bachelor of Biomedicine from the University of Melbourne.